Cannabidiol in the treatment of neuropsychiatric disorders: new paths
The action of cannabinoid drugs in L-dopa-induced dyskinesia: analysis of neuroinf...
Investigation of the molecular targets of cannabidiol and its possible interaction...
New perspectives in the use of drugs that modify atypical neurotransmitters in the...
Investigation of the participation of the ADAM10-NEGR1-FGFR2 pathway in vitro and ...
Neuroinflammatory reactions in in vitro models of Parkinson's Disease and L-dopa-i...
Study of the effects of chronic treatment with cannabidiol orally administered on ...